Global Biotech Ingredients Market Trends, Forecast, and Opportunities 2025

The global biotech ingredients market was valued at USD 62.1 Billion in 2024 and is projected to reach USD 94.5 Billion by 2033, growing at a CAGR of 4.29% during the forecast period of 2025-2033. This growth is driven by increasing demand for sustainable and natural biotech-derived ingredients across pharmaceuticals, cosmetics, and food and beverage sectors, supported by innovations in biotechnology and stringent regulations favoring eco-friendly products. Europe dominated the market in 2024 with a 37.6% share.

STUDY ASSUMPTION YEARS

Base Year: 2024
Historical Years: 2019-2024
Forecast Year/Period: 2025-2033

BIOTECH INGREDIENTS MARKET KEY TAKEAWAYS

Current Market Size: USD 62.1 Billion in 2024
CAGR: 4.29% from 2025 to 2033
Forecast Period: 2025-2033
Europe leads the market with a 37.6% share, driven by strict regulatory frameworks and demand for sustainable products.
The rising demand for natural and sustainable products in food and beverage propels market growth.
Technological advancements such as fermentation and gene editing enhance ingredient quality and production efficiency.
Increasing adoption in personal care and cosmetics due to demand for non-toxic, natural ingredients.
Government initiatives and regulatory support in regions like the US and Europe boost market growth.

Sample Request Link: https://www.imarcgroup.com/Biotech-Ingredients-Market/requestsample

MARKET GROWTH FACTORS

The increasing demand for natural and sustainable items, especially in the food and beverage sector, is a major growth driver. Consumers prefer eco-friendly and plant-based alternatives, prompting companies to innovate with biotech-derived ingredients. The pharmaceutical industry also fuels growth by utilizing biotech ingredients in drug formulations and vaccines. The rising trend for bio-based active ingredients in cosmetics further supports market expansion, reinforced by stricter regulations on synthetic chemicals, encouraging the shift towards biotech solutions.

Advancements in biotechnology and synthetic biology significantly propel market growth. Innovations like fermentation methodologies and gene editing enable the production of high-quality ingredients with improved efficacy. These technologies reduce reliance on traditional raw materials, lower environmental impacts, and cut manufacturing costs. For instance, Integrated DNA Technologies expanded its synthetic biology facilities in 2024, enhancing production capacity and product diversity, exemplifying the industry's momentum.

The personal care and cosmetics industries are adopting biotech ingredients rapidly to meet consumer demand for natural, non-toxic products. Ingredients such as hyaluronic acid, peptides, and enzymes offer superior efficacy and sustainability compared to synthetic alternatives. Cosmetic companies are increasingly leveraging bio-based compounds to develop products with anti-aging and skin hydration benefits, exemplified by new product ranges like Nuxe's Nuxuriance Ultra Alfa, which incorporates natural-origin ingredients developed using green technology.

MARKET SEGMENTATION

Analysis by Type:

Yeast: Not detailed in the source but included as a key type segment.
Algae: Accounts for 44.6% market share in 2024; valued for sustainable cultivation, excellent nutritional profile rich in fatty acids, antioxidants, and vitamins, widely used in food & beverages, pharmaceuticals, and cosmetics sectors.
Others: Not specified further in source.

Analysis by Application:

Food and Beverages: Utilized for creating healthier food products through biotech processes.
Personal Care and Cosmetics: Holds 38.7% market share; driven by demand for sustainable and safe cosmetics, integrating biotech actives like enzymes and peptides for better skincare effectiveness.
Cleaning Products: Not elaborated in detail but included as a category.
Others: Not specified further.

REGIONAL INSIGHTS

Europe is the dominant region in the biotech ingredients market, holding a 37.6% share in 2024. The market is propelled by strict regulations favoring sustainable and natural products in key sectors such as cosmetics and pharmaceuticals. Europe benefits from advanced biotechnology infrastructure, strong governmental R&D support, and regulatory approvals promoting algae-based ingredients while reducing toxic chemical use. For example, in February 2024, the European Commission approved over 20 algae species for food supplements, streamlining market access and reducing sector costs.

RECENT DEVELOPMENTS & NEWS

December 2024: Estée Lauder Companies launched its BioTech Hub in Olen, Belgium, focusing on bio-based ingredient alternatives derived from plant, yeast, and bacterial origins.
October 2024: Amyris secured a USD 12.3M contract from BioMaP-C to develop small-molecule drugs using synthetic biology and precision fermentation compliant with GMP standards.
April 2024: Ole Hyva Luonnontuote introduced the Meri cosmetics line using seaweed-derived molecules, including algae-based alginate CAERULO.
April 2024: GreenCoLab showcased food prototypes featuring algae burgers, sturgeon roe substitutes, and microalgae craft beer promoting algae as a sustainable vegan ingredient.
January 2024: Danstar Ferment AG, subsidiary of Lallemand Inc., acquired Swiss biotech company Evolva AG, focusing on natural yeast-derived ingredients for cosmetics and health products.

KEY PLAYERS

AbbVie Inc.
Advanced Biotech
Amyris Inc.
Becton Dickinson and Company
Bell Flavors & Fragrances Inc.
Bruker Corporation
Evolva AG
Evonik Industries AG
GlaxoSmithKline plc.
International Flavors & Fragrances Inc.
Merck KGaA
Sanofi SA

Customization Note

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.